Response rates by 24 months
| Responses achieved by 24 mo . | Dasatinib, N = 259 . | Imatinib, N = 260 . | ||
|---|---|---|---|---|
| n . | % (95% CI) . | n . | % (95% CI) . | |
| Complete cytogenetic response | 223 | 86 (81-90) | 213 | 82 (77-86) |
| Confirmed complete cytogenetic response | 208 | 80 (75-85) | 193 | 74 (68-79) |
| Major molecular response | 165 | 64 (58-70) | 120 | 46 (40-52) |
| BCR-ABL transcript level reduction to ≤ 0.0032% | 44 | 17 (13-22) | 22 | 8 (5-13) |
| Responses achieved by 24 mo . | Dasatinib, N = 259 . | Imatinib, N = 260 . | ||
|---|---|---|---|---|
| n . | % (95% CI) . | n . | % (95% CI) . | |
| Complete cytogenetic response | 223 | 86 (81-90) | 213 | 82 (77-86) |
| Confirmed complete cytogenetic response | 208 | 80 (75-85) | 193 | 74 (68-79) |
| Major molecular response | 165 | 64 (58-70) | 120 | 46 (40-52) |
| BCR-ABL transcript level reduction to ≤ 0.0032% | 44 | 17 (13-22) | 22 | 8 (5-13) |
CI indicates confidence interval.